These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8127455)

  • 21. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
    Saito Y; Nakamura K; Miyaji K; Akagi S; Mizoguchi H; Ogawa A; Fuke S; Fujio H; Kiyooka T; Nagase S; Kohno K; Morita H; Kusano KF; Matsubara H; Ohe T; Ito H
    J Pharmacol Sci; 2012; 120(3):206-12. PubMed ID: 23117888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of invasive ergometric exercise to assess the hemodynamic response to nicardipine.
    Cody RJ
    Am J Cardiol; 1987 Jun; 59(17):20J-24J. PubMed ID: 3604921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs.
    Yi GH; Burkhoff D; Zhang H; Zhu SM; Zwas D; Wang J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):760-6. PubMed ID: 9694931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravenous nicardipine: a new calcium antagonist for perioperative use].
    Muñoz Alameda LE; Barcina Sánchez M
    Rev Esp Anestesiol Reanim; 2001 Feb; 48(2):71-80. PubMed ID: 11257955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 2: Effect on myocardial metabolism.
    Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
    Arzneimittelforschung; 1998 Feb; 48(2):133-7. PubMed ID: 9541722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current applications for nicardipine in invasive and interventional cardiology.
    Fischell TA; Maheshwari A
    J Invasive Cardiol; 2004 Aug; 16(8):428-32. PubMed ID: 15282420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nicardipine-induced gingival hyperplasia].
    Pascual-Castroviejo I; Pascual Pascual SI
    Neurologia; 1997 Jan; 12(1):37-9. PubMed ID: 9131913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New cardiac drugs.
    Kikura M; Levy JH
    Int Anesthesiol Clin; 1995; 33(1):21-37. PubMed ID: 7635556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicardipine is a safe and effective agent in pediatric hypertensive emergencies.
    Tenney F; Sakarcan A
    Am J Kidney Dis; 2000 May; 35(5):E20. PubMed ID: 10793049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of heart failure with calcium channel blockers?].
    Erdmann E
    Herz; 1995 Aug; 20 Suppl 2():1-2. PubMed ID: 7557833
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
    Tikkanen I; Johnston CI
    Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Calcium channel blockers and mild congestive heart failure: advantage or disadvantage?].
    Airaksinen J
    Duodecim; 1991; 107(22):1872-5. PubMed ID: 1365966
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of beta-blockers in chronic congestive heart failure.
    Mahanonda N; Samranthin M; Panyarachun S
    J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of calcium antagonists in circulatory failure in elderly patients with hypertension].
    Orynchak MA
    Ter Arkh; 1989; 61(12):36-41. PubMed ID: 2629143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.
    Aronson S
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):465-72. PubMed ID: 19419254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term hemodynamic effects of mibefradil in dogs with chronic heart failure: comparison with diltiazem.
    Shimoyama H; Sabbah HN; Tanimura M; Borzak S; Goldstein S
    J Pharmacol Exp Ther; 1998 May; 285(2):746-52. PubMed ID: 9580622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
    Elis A; Bental T; Kimchi O; Ravid M; Lishner M
    Clin Pharmacol Ther; 1998 Jun; 63(6):682-5. PubMed ID: 9663183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.